Bill Weld: Cannabis Should Be a States' Rights Issue
The federal government could legalize marijuana in the [next five years](https://cheddar.com/videos/bill-weld-dominoes-are-falling-to-legalize-weed), said the former Massachusetts governor Bill Weld. Though, he said states should be able to decide the issue for themselves.
"Once you can do research on it, the arguments against it are going to be increasingly slim," said Weld on Thursday in an interview with Cheddar.
There are 29 states that allow medicinal use of cannabis, and nine states that have legalized recreational use of marijuana.
"We'd like to see cannabis descheduled as a Class I narcotic in Washington so that states would be free to do what they want," said Weld. "Right now there's a rub between federal and state law enforcement."
Weld and the former House Speaker John Boehner joined the board of the cannabis producer Acreage Holdings last week.
Boehner had long been an opponent of legal marijuana, but Weld said his new colleague changed his mind because the public's perception of the drug had changed.
For full interview, [click here](https://cheddar.com/videos/bill-weld-joins-acreage-board).
Skift airline reporter Meghna Maharishi breaks down how the government shutdown is hitting air traffic control—and what it means for travelers and flight safety
Aya Kantorovich, Co-CEO of August Digital, breaks down Bitcoin’s surge, crypto ETFs, institutional investment trends, and the future of safer crypto access.
Most members of the Federal Reserve’s interest-rate setting committee supported further reductions to its key interest rate this year, minutes from last month’s meeting showed.
Sinead O’Sullivan breaks down Taylor Swift’s genius marketing for The Life of a Showgirl, which just set the record for most albums sold in a single week.
Markets are emerging from a turbulent Q3. Horizon’s Mike Dickson shares insights on interest rates, small caps, and where investors should look in Q4 and beyond
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
